AU1385801A - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number: AU1385801A
Authority: AU; Australia
Prior art keywords: pharmaceutical formulations; formulations; pharmaceutical
Prior art date: 1999-10-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU13858/01A

Inventor

Anthony J. Taylor

David A. Wyatt

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-21

Filing date

2000-10-19

Publication date

2001-04-30

2000-10-19 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2001-04-30 Publication of AU1385801A publication Critical patent/AU1385801A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Otolaryngology (AREA)
Emergency Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AU13858/01A 1999-10-21 2000-10-19 Pharmaceutical formulations Abandoned AU1385801A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9924992		1999-10-21
GBGB9924992.2A GB9924992D0 (en)	1999-10-21	1999-10-21	Pharmaceutical aerosol formulations
PCT/EP2000/010306 WO2001028535A2 (en)	1999-10-21	2000-10-19	Pharmaceutical formulations comprising a combination of s-salmeterol and fluticasone propionate

Publications (1)

Publication Number	Publication Date
AU1385801A true AU1385801A (en)	2001-04-30

Family

ID=10863173

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU11411/01A Abandoned AU1141101A (en)	1999-10-21	2000-10-19	Pharmaceutical aerosol formulations comprising s-salmeterol
AU13858/01A Abandoned AU1385801A (en)	1999-10-21	2000-10-19	Pharmaceutical formulations

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU11411/01A Abandoned AU1141101A (en)	1999-10-21	2000-10-19	Pharmaceutical aerosol formulations comprising s-salmeterol

Country Status (3)

Country	Link
AU (2)	AU1141101A (en)
GB (1)	GB9924992D0 (en)
WO (2)	WO2001028535A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR030516A1 (en) *	2000-08-31	2003-08-20	Glaxo Group Ltd	USE OF A COMBINATION OF SALMETEROL AND FLUTICASONA
GB0021927D0 (en) *	2000-09-07	2000-10-25	Glaxo Group Ltd	Use of pharmaceutical combination
GB0106031D0 (en) *	2001-03-12	2001-05-02	Glaxo Group Ltd	Use
GB0124523D0 (en) *	2001-10-12	2001-12-05	Glaxo Group Ltd	Pharmaceutical combination
AU2004241746A1 (en) *	2003-05-22	2004-12-02	Nycomed Gmbh	Salmeterol and ciclesonide combination
ATE552032T1 (en) *	2005-07-14	2012-04-15	Lithera Inc	IMPROVED LIPOLYTIC FORMULATION WITH SUSTAINED RELEASE FOR THE AREA TREATMENT OF FAT TISSUE
US9132084B2 (en)	2009-05-27	2015-09-15	Neothetics, Inc.	Methods for administration and formulations for the treatment of regional adipose tissue
TR201000685A2 (en) *	2010-01-29	2011-08-22	Bi̇lgi̇ç Mahmut	Pharmaceutical preparations containing salmeterol and fluticasone.
CN105832681A (en)	2010-11-24	2016-08-10	纽赛蒂克斯公司	Selective, lipophilic, and long-acting beta agonist mono-therapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL104068A (en) *	1991-12-12	1998-10-30	Glaxo Group Ltd	Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
DK0820323T3 (en) *	1995-04-14	2003-11-24	Smithkline Beecham Corp	Inhalator for metered doses of salmeterol
US6254882B1 (en) *	1997-09-16	2001-07-03	Sepracor Inc.	Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol

1999
- 1999-10-21 GB GBGB9924992.2A patent/GB9924992D0/en not_active Ceased
2000
- 2000-10-19 AU AU11411/01A patent/AU1141101A/en not_active Abandoned
- 2000-10-19 AU AU13858/01A patent/AU1385801A/en not_active Abandoned
- 2000-10-19 WO PCT/EP2000/010306 patent/WO2001028535A2/en active Application Filing
- 2000-10-19 WO PCT/EP2000/010305 patent/WO2001028514A1/en active Application Filing

Also Published As

Publication number	Publication date
WO2001028535A3 (en)	2002-01-10
GB9924992D0 (en)	1999-12-22
AU1141101A (en)	2001-04-30
WO2001028514A1 (en)	2001-04-26
WO2001028535A2 (en)	2001-04-26

Publication	Publication Date	Title
AU1071301A (en)	2001-05-14	Pharmaceutical compounds
AU3192700A (en)	2000-10-04	Medicinal compositions
HUP0202235A3 (en)	2004-05-28	Preserved pharmaceutical formulations
AU3556400A (en)	2000-10-04	Pharmaceutical compositions
AU4328800A (en)	2000-11-10	Pharmaceutical formulation
AU2005300A (en)	2000-08-07	Medicinal compositions
AU1887401A (en)	2001-06-25	Medicinal composition
AU6715600A (en)	2001-03-19	Pharmaceutical formulations
AU6460400A (en)	2001-03-13	Pharmaceutical compositions
AU4977300A (en)	2000-11-17	Pharmaceutical formulations
AU1385801A (en)	2001-04-30	Pharmaceutical formulations
AU6460200A (en)	2001-03-13	Pharmaceutical compositions
AU5722900A (en)	2001-01-09	Pharmaceutical compounds
AU3839900A (en)	2000-11-10	Pharmaceutical formulation
AU6460100A (en)	2001-03-13	Pharmaceutical compositions
AU6460300A (en)	2001-03-13	Pharmaceutical compositions
AU4914400A (en)	2000-11-21	Novel pharmaceutical composition
AU1388501A (en)	2001-06-06	Pharmaceutical formulation
GB9906126D0 (en)	1999-05-12	Pharmaceutical formulations
GB9930578D0 (en)	2000-02-16	Pharmaceutical formulations
AU5182099A (en)	2000-03-06	Pharmaceutical formulation
AU4504201A (en)	2001-06-12	Drug preparations
AU2001230490A1 (en)	2002-06-11	Pharmaceutical formulation
GB9903177D0 (en)	1999-04-07	Pharmaceutical formulations
GB9905983D0 (en)	1999-05-12	Pharmaceutical formulations

Legal Events

Date	Code	Title	Description
2002-06-20	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase